Artykuł
Popandemiczny powrót grypy – jakich zmian i wyzwań można oczekiwać w sezonie 2022/2023?
17.10.2022
ABSTRACT
High-risk pregnancy – should pregnant women be vaccinated against influenza and pertussis, and when?
In pregnancy, the course of influenza may be marked by more severe symptoms and the onset of complications, often requiring hospital admission, while pertussis is very dangerous particularly to neonates and infants who cannot be vaccinated on account of their age or the presence of contraindications. Flu and pertussis vaccinations are accordingly recommended to all pregnant women. Despite official recommendations in many countries, including Poland, influenza and pertussis vaccination coverage among pregnant women continues to be very low. Furthermore, many doctors are still not knowledgeable enough about the purpose and safety of vaccination in pregnancy. This article sets out to dispel doubts regarding vaccination in pregnant women. The authors provide a rationale for influenza and pertussis vaccination in pregnancy and explain how vaccination against these diseases influences the course of pregnancy and the developing foetus. Possible sequelae of the infections for the mother and the child are presented and research evidence for the safety of these vaccinations is adduced.
Piśmiennictwo
1. Kajfasz P. Krztusiec. W: Dziubek Z (red.). Choroby zakaźne i pasożytnicze. Warszawa: Wydawnictwo Lekarskie PZWL, 2010:161-7
2. Wysocki J. Krztusiec. W: Interna Szczeklika. Podręcznik chorób wewnętrznych. Kraków: Medycyna Praktyczna, 2013:2280-1
3. Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy. Sytuacja epidemiologiczna krztuśca w Polsce. https://www.pzh.gov.pl/serwisy-tematyczne/gromadzenie-danych/sytuacja-epidemiologiczna-krztusca-w-polsce/. Dostęp 30.07.2021
4. Centers for Disease Control and Prevention. Pertussis incidence by age group and year (1990-2019). https://www.cdc.gov/pertussis/surv-reporting/cases-by-age-group-and-year.html. Dostęp 30.07.2021
5. Australian Institute of Health and Welfare. Whooping cough in Australia. https:// www.aihw.gov.au/getmedia/303c1ab7-9b04-4544-9c5d-852c533ac87a/aihw-phe-236_WhoopingCough.pdf.asp. Dostęp 30.07.2021
6. Public Health England. Laboratory confirmed cases of pertussis in England. Annual report for 2020 supplementary data tables. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/992485/Laboratory_confirmed_cases_of_pertussis_in_England_supplementary_data_2020.pdf. Dostęp 30.07.2021
7. Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy. Szczepionka przeciw krztuścowi. https://szczepienia.pzh.gov.pl/szczepionki/krztusiec/?strona=5#kto-i-kiedy-powinien-zostac-zaszczepiony-przeciw-krztuscowi. Dostęp 30.07.2021
8. Forsyth K, Plotkin S, Tan T, et al. Strategies to decrease pertussis transmission to infants. Pediatrics 2015;135(6):e1475-82
9. Liko J, Koenig WJ, Cieslak PR. Suffer the infants: a severe case of pertussis in Oregon, 2012. Public Health Rep 2015;130(5):435-9
10. Payakachat N, Hadden KB, Ragland D. Promoting rates. Vaccine 2016;34:179-86
11. Carcione D, Regan AK, Tracey L, et al. The impact of parental postpartum pertussis vaccination on infection in infants: a population-based study of cocooning in Western Australia. Vaccine 2015;33(42):5654-61
12. Skoff TH, Faulkner AE, Liang JL, et al. Pertussis infections among pregnant women in the United States, 2012-2017. Clin Infect Dis 2020:ciaa1112
13. Olszyńska-Krowicka M. Grypa. W: Dziubek Z (red.). Choroby zakaźne i pasożytnicze. Warszawa: Wydawnictwo Lekarskie PZWL, 2010:258-65
14. World Health Organization. Influenza seasonal, 2018. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Dostęp 30.07.2021
15. Blanchard-Rohner G, Siegrist C. Vaccination during pregnancy to protect infants against influenza: why and why not? Vaccine 2011;29(43):7542-50
16. Naleway A, Smith W, Mullooly J. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006;28:47-53
17. Creanga A, Johnson T, Graitzer S, et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010;115:717-26
18. Liu SL, Wang J, Yang XH, et al. Pandemic influenza A(H1N1) 2009 virus in pregnancy. Rev Med Virol 2013;23(1):3-14
19. Jamieson D, Honein M, Rasmussen S, et al. H1N12009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-8
20. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the united states. JAMA 2010;303(15):1517-25
21. Mazagatos C, Delgado-Sanz C, Oliva J, et al.; Spanish Influenza Surveillance System. Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16. PLoS One 2018;13(8):e0200934
22. Meijer WJ, van Noortwijk AG, Bruinse HW, et al. Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand 2015;94(8):797-819
23. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998;148(11):1094-102
24. Leick-Courtois C, Haÿs S, Perpoint T, et al. Influenza A H1N1 in neonatal intensive care unit: analysis and lessons. Arch Pediatr 2011;18(10):1069-75
25. Stanwell-Smith R, Parker A, Chakraverty P, et al. Possible association of influenza A with fetal loss; investigation of cluster of spontaneous abortions and stillbirths. Commun Dis Rep 1994;4:28-32
26. Nishiura H. Excess risk of stillbirth during the 1918-1920 influenza pandemic in Japan. Eur J Obstet Gynecol Reprod Biol 2009;147(1):115
27. Hamela-Olkowska A, Szymkiewicz-Dangel J. Tachyarytmie u płodów – aktualny stan wiedzy. Ginekol Pol 2010;81:844-50
28. Louie JK, Acosta M, Jamieson DJ, et al.; California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362(1):27-35
29. Valvi C, Kulkarni R, Knikar A, et al. 2009H1N1 infection in a 1-day-old neonate. Ind J Med Sci 2010;64(12):549-52
30. Picone O, Bernabe-Dupont C, Vauloup-Fellous C, et al. A suspected case of in utero transmission of influenza a (H1N1) 2009. J Gynecol Obstet Biol Reprod (Paris) 2011;40(5):473-5
31. Poehling KA, Edwards KM, Weinberg GA, et al.; New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med 2006;355(1):31-40
32. Bhat N, Wright JG, Broder KR, et al.; Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005;353(24):2559-67
33. Antczak A, Kuchar E, Nitsch-Osuch A i wsp. Stanowisko ekspertów OPZG i PTGiP dotyczące szczepienia przeciw grypie kobiet w ciąży. Ginekol Perinatol Prakt 2020;5(3):112-8
34. Munoz FM, Greisinger AJ, Wehmanen OA, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005;192(4):1098-106
35. Pool V, Iskander J. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2006;194(4):1200
36. Moro P, Baumblatt J, Lewis P, et al. Surveillance of adverse events after seasonal influenza vaccination in pregnant women and their infants in the vaccine adverse event reporting system, July 2010-May 2016. Drug Saf 2017;40(2):145-52
37. Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al.; Vaccine Safety Datalink Team. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013;122(3):659-67
38. Black SB, Shinefield HR, France EK, et al.; Vaccine Safety Datalink Workgroup. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004;21(6):333-9
39. Winter K, Cherry JD, Harriman K. Effectiveness of prenatal tetanus, diphtheria and acellular pertussis vaccination on pertussis severity in infants. Clin Infect Dis 2017;64(1):9-14
40. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008;359(15):1555-64
41. Sheffield J, Roberts S, Lorimer M, et al. The efficacy and safety of influenza vaccination in pregnancy. Obstetrics AJOG: Society for Maternal-Fetal Medicine: 31st annual meetings: the pregnancy meeting. 2011:66
42. Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol 2015;125(1):212-26
43. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013;56(4):539-44
44. Halperin BA, Morris A, Mackinnon-Cameron D, et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011;53(9):885-92
45. Payakachat N, Hadden KB, Ragland D. Promoting Tdap immunization in pregnancy: associations between maternal perceptions and vaccination rates. Vaccine 2016;34(1):179-86
46. Maertens K, Caboré RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine 2016;34(1):142-50
47. Hayles EH, Cooper SC, Wood N, et al. What predicts postpartum pertussis booster vaccination? A controlled intervention trial. Vaccine 2015;33(1):228-36
48. Abu Raya B, Bamberger E, Almog M, Peri R, Srugo I, Kessel A. Immunization of pregnant women against pertussis: the effect of timing on antibody avidity. Vaccine 2015;33(16):1948-52
49. Shakib JH, Korgenski K, Sheng X, et al. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 2013;163(5):1422-6
50. Winter K, Nickell S, Powell M, et al. Effectiveness of prenatal versus postpartum tetanus, diphtheria and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis 2017;64(1):3-8
51. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384(9953):1521-8
52. Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis 2016;63(suppl 4):S236-43
53. Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill 2013;18(38):20587
54. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. JAMA 2014;312(18):1897-904
55. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014;349:g4219
56. Walls T, Graham P, Petousis-Harris H, et al. Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study. BMJ Open 2016;6(1):e009536
57. Petousis-Harris H, Walls T, Watson D, et al. Safety of Tdap vaccine in pregnant women: an observational study. BMJ Open 2016;6:e010911
58. Kharbanda EO, Vazquez-Benitez G, Lipkind HS, et al. Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. Vaccine 2016;34(7):968-73
59. Furuta M, Sin J, Ng ESW, et al. Efficacy and safety of pertussis vaccination for pregnant women – a systematic review of randomised controlled trials and observational studies. BMC Pregnancy Childbirth 2017;17(1):390
60. Sukumaran L, McCarthy NL, Kharbanda EO, et al. Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations. JAMA 2015;314(15):1581-7
61. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women. MMWR Morb Mortal Wkly Rep 2013;62(7):131-5
62. Koerner J, Forinash AB, Yancey AM, et al. Administration rates of the Tdap vaccine in obstetric patients. Ann Pharmacother 2018;52(7):655-61
63. Gaudelus J, Martinot A, Denis F, et al. Vaccination of pregnant women in France. Med Mal Infect 2016;46(8):424-8
64. Laurie L, Lambert SB, Jones L, et al. Influenza and pertussis vaccine uptake during pregnancy among Australian women in south-east Queensland, Australia. Aust N Z J Public Health 2021
65. Rodríguez-Blanco N, Tuells J, Vila-Candel R, et al. Adherence and concordance of influenza and pertussis vaccination coverage in pregnant women in Spain. Int J Environ Res Public Health 2019;16(4):543
66. Mohammed H, McMillan M, Roberts CT, et al. A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy. PLoS One 2019;14(3):e0214538
67. Psarris A, Sindos M, Theodora M, et al. Routine immunizations during pregnancy, doctors' compliance and patient hesitancy: a two stage study on vaccination uptake. Eur J Obstet Gynecol Reprod Biol 2019;243:36-40
68. Ford AJ, Alwan NA. Use of social networking sites and women's decision to receive vaccinations during pregnancy: a cross-sectional study in the UK. Vaccine 2018;36(35):5294-303
